MPH alum urges prostate surgery patients to not only focus on surgeon experience

January 4, 2016

Men who get prostate cancer surgery at hospitals that do a lot of these procedures may have better results, and those better outcomes might help offset the added cost of care at specialized facilities, a U.S. study suggests. Patients should be careful not to focus on the surgeon's experience level until after they determine whether they actually need surgery, because many men with slow-growing tumors don't necessarily need prostatectomies, said Dr.

Hypertension-related visits to emergency rooms on rise in U.S. says MPH alumna

December 10, 2015

The number and percentage of patients treated at emergency departments for hypertension are on the rise across the United States, according to a Vanderbilt study published recently in The American Journal of Cardiology. “We found that around 25 percent of all emergency department visits involved patients with hypertension, and that the rate of hypertension-related visits has gone up more than 20 percent since 2006,” said Candace McNaughton, M.D., MPH, assistant professor of Emergency Medicine, one of the researchers.

MPH alum named Nashville Health Care Council fellow

December 8, 2015

The Nashville Health Care Council is delving into innovation, consumerism and retail health care for its 2016 Council Fellows, which is stitching together a diverse collection leaders from around the city's health care community. Headed by former Sen. Bill Frist and Vanderbilt Owen Graduate School of Management health care and economics professor Larry Van Horn, the council accepted 30 Fellows for the Class of 2016.

New diagnoses of prostate cancer decreased according to study from MPH alum

December 1, 2015

New prostate cancer diagnoses declined by almost 30% in the first year after the U.S. Preventive Services Task Force (USPSTF) recommended against routine screening PSA tests, a review of a national database showed. An analysis by disease stage at diagnosis showed that the number of new diagnoses of intermediate- and high-risk prostate cancer also decreased, which could have potentially ominous implications if the trend persists, Daniel A.